Samy Suissa


Professor Samy Suissa is Director of the Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, and a Distinguished James McGill Professor, Departments of Epidemiology and Biostatistics and of Medicine, McGill University. Dr. Suissa heads the Canadian Network for Observational Drug Effect Studies (CNODES) and the McGill Pharmacoepidemiology Research Unit. He was the founding Director of the Quebec Research Network on Medication Use, funded by the FRSQ.

Professor Suissa has chaired and served on several review committees for the Fonds de la recherche en santé du Québec (FRSQ) and the Canadian Institutes of Health Research (CIHR), including chairing the FRSQ Chercheur-National awards committee. He served on several advisory boards, such as the External Advisory Board of PROTECT, the drug safety consortium formed by the European Innovative Medicines Initiative (IMI). He has served on the editorial boards of various scientific journals, including Diabetes Care, Gut, Pharmacoepidemiology and Drug Safety, the European Respiratory Journal, Lancet Respiratory Medicine, Multidisciplinary Respiratory Medicine, and the Journal of COPD. He is Co-head of the Research Methodology, Policy & General Interest for Faculty 1000 Medicine. He served as Associate Editor of the Journal of Disease Management and Health Outcomes, as well as Treatments in Respiratory Medicine. He was an elected member of the boards of directors of the International Society of Pharmacoepidemiology and of the Canadian Association for Pharmaceutical Therapeutics.

Professor Suissa received Chercheur-Boursier awards from the FRSQ, a Senior Scientist award from the Medical Research Council of Canada (MRC) and the Distinguished Scientist award from Canadian Institute of Health Research (CIHR).  He is a fellow of the Royal Society of Canada and of the Canadian Academy of Health Science, and was conferred the FC Donders Professor Award from the Universiteit Utrecht, Netherlands.